4.4 Article

The Future Burden of Colorectal Cancer Among US Blacks and Whites

期刊

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/jnci/djx287

关键词

-

类别

向作者/读者索取更多资源

Although overall colorectal cancer (CRC) incidence rates in the United States are declining, rates among younger persons (age < 55 years) are increasing, particularly among US whites. We assessed how these trends will impact the future burden (up to 2040) of CRC among US blacks and whites using an age-period-cohort model. Over the last four decades (1973 to 2014), CRC incidence rates for all ages (both sexes) have dropped by 6.6% and 33.9% in US blacks and whites, respectively. Yet we predict an upward turn in CRC cancer incidence rates over the next quarter century, particularly among US whites. The age standardized rates of CRC were 55.4 and 43.2 per 100 000 among US blacks and whites in 2014, respectively, and are projected to be 49.5 and 43.1 in 2040, respectively. Future interventions are needed to reduce the striking differences in CRC incidence between blacks and whites.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Oncology

The shifting epidemiology of lung cancer in Asian and Asian diaspora populations: Implications for clinical and global health policy research

Edward Christopher Dee, Patricia Mae G. Santos, Freddie Bray

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Gastroenterology & Hepatology

International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study)

Melina Arnold, Eileen Morgan, Aude Bardot, Mark J. Rutherford, Jacques Ferlay, Alana Little, Bjorn Moller, Oliver Bucher, Prithwish De, Ryan R. Woods, Nathalie Saint-Jacques, Anna T. Gavin, Gerda Engholm, Michael P. Achiam, Geoff Porter, Paul M. Walsh, Sally Vernon, Serena Kozie, Agnihotram Ramanakumar, Charlotte Lynch, Samantha Harrison, Neil Merrett, Dianne L. O'Connell, Tom Mala, Mark Elwood, John Zalcberg, Dyfed W. Huws, David Ransom, Freddie Bray, Isabelle Soerjomataram

Summary: This study provides the first international comparison of oesophageal and gastric cancer survival by stage at diagnosis and histological subtype across high-income countries with similar access to healthcare. The results show that survival from these cancers varies across countries, particularly for localised disease, and differences in treatment, cancer registration practice, and staging methods may impact these comparisons.
Article Oncology

Global patterns of Hodgkin lymphoma incidence and mortality in 2020 and a prediction of the future burden in 2040

Deependra Singh, Salvatore Vaccarella, Andrea Gini, Neimar De Paula Silva, Eva Steliarova-Foucher, Freddie Bray

Summary: This study examines the global patterns of Hodgkin lymphoma in 2020 and predicts the future incidence and mortality burden. The findings show that males have consistently higher incidence and mortality rates across different regions. Incidence rates vary significantly by regions, with the highest rates observed in Southern Europe, while mortality rates are elevated in Western Asia and Northern Africa. The study predicts an increase in the number of cases by 2040.

INTERNATIONAL JOURNAL OF CANCER (2022)

Review Oncology

Burden of Kaposi sarcoma according to HIV status: A systematic review and global analysis

Ahmadaye Ibrahim Khalil, Silvia Franceschi, Catherine de Martel, Freddie Bray, Gary M. Clifford

Summary: This study estimates the burden of HIV-associated and non-HIV-associated Kaposi sarcoma (KS) globally by investigating the HIV prevalence and KS cases. The results highlight the significant burden of HIV-associated KS in sub-Saharan Africa, even in the era of combined antiretroviral therapy.

INTERNATIONAL JOURNAL OF CANCER (2022)

Article Oncology

Age-specific burden of cervical cancer associated with HIV: A global analysis with a focus on sub-Saharan Africa

Ahmadaye Ibrahim Khalil, Tharcisse Mpunga, Feixue Wei, Iacopo Baussano, Catherine de Martel, Freddie Bray, Dominik Stelzle, Scott Dryden-Peterson, Antoine Jaquet, Marie-Josephe Horner, Olutosin A. Awolude, Mario Jesus Trejo, Washington Mudini, Amr S. Soliman, Mazvita Sengayi-Muchengeti, Anna E. Coghill, Matthys C. van Aardt, Hugo De Vuyst, Stephen E. Hawes, Nathalie Broutet, Shona Dalal, Gary M. Clifford

Summary: HIV substantially worsens HPV carcinogenicity and contributes to excess cervical cancer cases, especially in sub-Saharan Africa. Quantifying cervical cancer burden by age and HIV status can inform prevention efforts in this region. HIV has a greater impact on younger women and HIV-attributable cases tend to shift towards younger age groups.

INTERNATIONAL JOURNAL OF CANCER (2022)

Article Oncology

Global and national trends in the age-specific sex ratio of esophageal cancer and gastric cancer by subtype

Shaoming Wang, Rongshou Zheng, Melina Arnold, Christian Abnet, Hongmei Zeng, Siwei Zhang, Ru Chen, Kexin Sun, Li Li, Lan An, Freddie Bray, Wenqiang Wei, Jie He

Summary: A male predominance was observed in esophageal and gastric cancers across the world from 2003 to 2012, with variations in male-to-female incidence rate ratios by age. Further investigation is needed to understand the underlying etiologies of these cancers by histological subtype and subsite.

INTERNATIONAL JOURNAL OF CANCER (2022)

Article Gastroenterology & Hepatology

Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN

Eileen Morgan, Melina Arnold, A. Gini, V Lorenzoni, C. J. Cabasag, Mathieu Laversanne, Jerome Vignat, Jacques Ferlay, Neil Murphy, Freddie Bray

Summary: Colorectal cancer is the third most common cancer worldwide, with the highest incidence rates in Australia/New Zealand and Europe, and the lowest rates in Africa and Southern Asia. The burden of colorectal cancer is projected to increase by 2040, with the majority of cases predicted to occur in high HDI countries.
Article Oncology

Global burden of HPV-attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: A worldwide analysis

Ashish A. Deshmukh, Haluk Damgacioglu, Damien Georges, Kalyani Sonawane, Jacques Ferlay, Freddie Bray, Gary M. Clifford

Summary: Squamous cell carcinoma of the anus (SCCA), caused by HPV, has a higher incidence in persons living with HIV (PLWHIV). Globally, the number of female SCCA cases is twice that of males, with a higher burden in countries with a very high Human Development Index (HDI). Approximately 21% of male SCCA cases globally occur in PLWHIV, while only about 3% of female SCCA cases occur in this population.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Gastroenterology & Hepatology

Global burden of primary liver cancer in 2020 and predictions to 2040

Harriet Rumgay, Melina Arnold, Jacques Ferlay, Olufunmilayo Lesi, Citadel J. Cabasag, Jerome Vignat, Mathieu Laversanne, Katherine A. McGlynn, Isabelle Soerjomataram

Summary: The burden of liver cancer varies across the world, and it is a major cause of death in many countries. The number of liver cancer cases and deaths is predicted to increase, with a significant rise expected by 2040.

JOURNAL OF HEPATOLOGY (2022)

Article Oncology

Do investments in cancer registry databases and tools bring added value? NORDCAN as an example

Hans Henrik Storm, Siri Laronningen, Freddie Bray

Summary: The KIN project provided timely cancer statistics for cancer control planning in the Nordic countries, and the development of NORDCAN project reduced investment costs and increased scientific value.

ACTA ONCOLOGICA (2023)

Article Oncology

Recent Mortality Patterns and Time Trends for the Major Cancers in 47 Countries Worldwide

Ephrem Sedeta, Hyuna Sung, Mathieu Laversanne, Freddie Bray, Ahmedin Jemal

Summary: Using the World Health Organization mortality database, this study examines patterns and trends in cancer mortality rates for eight common forms of cancer in 47 countries across five continents (except Africa). The results show significant variations in cancer-specific mortality rates among countries, with infection-related and tobacco-related cancers having the largest differences. Most countries have seen a decrease in overall cancer mortality rates, except for lung cancer in females and liver cancer in males. The findings emphasize the importance of implementing targeted cancer prevention and control programs globally to reduce the growing cancer burden.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2023)

Article Oncology

Cancer inequalities in incidence and mortality in the State of Sao Paulo, Brazil 2001-17

Adeylson Guimaraes Ribeiro, Jacques Ferlay, Salvatore Vaccarella, Maria do Rosario Dias de Oliveira Latorre, Jose Humberto Tavares Guerreiro Fregnani, Freddie Bray

Summary: There are significant disparities in cancer incidence and mortality based on area-level socioeconomic status (SES) in Sao Paulo, Brazil. A clear SES-cancer gradient was observed in the city of Sao Paulo, with higher SES areas having higher cancer incidence rates. In the Barretos region, there was no significant social gradient for cancer mortality. In Sao Paulo, higher SES was associated with higher incidence rates for colorectal, lung, female breast, and prostate cancer, while lower SES was associated with higher incidence and mortality rates for cervical cancer in both regions.

CANCER MEDICINE (2023)

Article Public, Environmental & Occupational Health

Projections of Lung Cancer Incidence by 2035 in 40 Countries Worldwide: Population-Based Study

Ganfeng Luo, Yanting Zhang, Jaione Etxeberria, Melina Arnold, Xiuyu Cai, Yuantao Hao, Huachun Zou

Summary: The future incidence of lung cancer is predicted to decrease among males and increase among females in most countries. The peak of female lung cancer incidence is expected to occur after the 2020s in European, Eastern Asian, and Oceanian countries. The highest ASRs are projected to occur among males in Belarus and among females in Denmark in 2035.

JMIR PUBLIC HEALTH AND SURVEILLANCE (2023)

Article Oncology

Alberta Childhood Cancer Survivorship Research Program

Andrew Harper, Fiona Schulte, Gregory M. T. Guilcher, Tony H. Truong, Kathleen Reynolds, Maria Spavor, Natalie Logie, Joon Lee, Miranda M. Fidler-Benaoudia

Summary: Treatments for childhood cancer can have negative long-term effects. This study presents the Alberta Childhood Cancer Survivorship Research Program, its cohort, and statistical outcomes. The cohort consisted of 2580 childhood cancer survivors, mostly male, diagnosed between 0 and 4 years old with leukemia, CNS tumor, or lymphoma. The median time since diagnosis was 5.5 years overall and 10.4 years for 5-year survivors. During follow-up, 82 subsequent cancers were diagnosed, along with various healthcare events and deaths.

CANCERS (2023)

Article Oncology

Symptom severity and trajectories among adolescent and young adult patients with cancer

Andrew Harper, Nicole Maseja, Reilly Parkinson, Mohammadreza Pakseresht, Sarah Mckillop, Jan-Willem Henning, Linda Watson, Colleen Cuthbert, Winson Cheung, Miranda M. Fidler-Benaoudia

Summary: Research findings indicated that adolescents and young adults experience significant symptom burden during the year following a cancer diagnosis, with high levels of tiredness, poor well-being, and anxiety reported. Symptom severity is influenced by various factors, including metastatic disease, female sex, treatment types received, and age at diagnosis.

JNCI CANCER SPECTRUM (2023)

暂无数据